Clinical Trials on Cutaneous Polyarteritis Nodosa in France

Total 145 results

Centre Hospitalier Universitaire de Nīmes

Recruiting

Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology) (CQR-F)

Rheumatoid Polyarthritis

France
Centre Hospitalier Universitaire, Amiens

Unknown

Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis (METHO-PR)

Methotrexate | Polyarthritis; Rheumatoid

France
CEN Biotech
MYEXPRESION

Recruiting

Performance of PEAR 2.0 Software in Prescribing Biotherapy in Patients With Rheumatoid Arthritis

Polyarthritis; Rheumatoid

France
University Hospital, Brest

Completed

Biotherapy Treatment on Features of Microcrystalline Polyarthritis (FUMBLE)

Crystal-Induced Arthritis

France
Centre Hospitalier Universitaire de Nice

Unknown

Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo (ADEM)

Polyarthritis

France
Medacta International SA

Active, not recruiting

The Medacta International AMIStem-P Post-Marketing Surveillance Study

Arthrosis | Congenital Hip Dysplasia | Traumatic Arthritis | Rheumatoid Polyarthritis | Avascular Necrosis of the Femoral Head

France
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (CORTAGE)

Vasculitis | Wegener's Granulomatosis | Microscopic Polyangiitis | Churg-Strauss Syndrome | Polyarteritis Nodosa

France
Centre Jean Perrin

Withdrawn

Efficacy Assessment of CT-guided Hook Wire Localization of Lung Nodes Before Thoracoscopy (HARNO)

Nodes, Lung

France
Assistance Publique - Hôpitaux de Paris

Completed

Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) (CHUSPAN2)

MPA | PAN or EGPA With FFS=0 | At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids

France
CHU de Reims

Unknown

Multiple Fields Radiotherapy Versus Intravenous Rituximab in the Treatment of Indolent Cutaneous Lymphomas B-cell With Multiple or Recurrent Lesions (RADIO-LYMPH)

Indolent Cutaneous B Cell Lymphomas

France
Assistance Publique - Hôpitaux de Paris

Unknown

Early Diagnosis of Mycosis Fungoides (DIAPREMYF)

Cutaneous T Cell Lymphoma

France
Rennes University Hospital

Completed

Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma (TgBEX)

Hypertriglyceridemia | Cutaneous T Cell Lymphoma

France
Assistance Publique - Hôpitaux de Paris
U.S. Army Medical Research and Development Command

Completed

WR 279,396 for the Treatment of Cutaneous Leishmaniasis (PAGELEC)

Cutaneous Leishmaniasis

France
Biogen

Enrolling by invitation

A Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adults With Active Subacute Cutaneous Lupus Erythematosus (CLE) and/or Chronic CLE With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE)

Subacute Cutaneous Lupus Erythematosus | Chronic Cutaneous Lupus Erythematosus

Spain, United States, France, Switzerland, Sweden
Poitiers University Hospital

Completed

Accuracy of Zero Heat Flux Cutaneous Temperature in Intensive Care Adults (TempCore)

Continuous Non Invasive Cutaneous Temperature | Zero Heat Flux Method | Esophageal Temperature | Arterial Temperature | Intracerebral Temperature

France
Alpha Tau Medical LTD.

Recruiting

Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors

Skin Cancer | Cutaneous Tumor | Cutaneous Metastasis

France
Hospices Civils de Lyon

Recruiting

Control Cohort CTRL COH (CTRL COH)

Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis

France
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World

Cutaneous Leishmaniasis

France, Tunisia
University Hospital, Toulouse

Not yet recruiting

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients (HCQMa)

Mastocytosis

France
Galderma R&D

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)

Cutaneous T Cell Lymphoma

United States, France, Germany
Onxeo

Completed

A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma

Austria, France, Germany, Switzerland
University Hospital, Toulouse

Unknown

Improvement of Pigmented Skin Lesions in Patients With Mastocytosis After Performing 2 Sessions of Pigment Laser (LaserMasto)

Cutaneous Mastocytosis

France
Ramsay Générale de Santé
European Clinical Trial Experts Network

Recruiting

Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV) (DERMOCTAV)

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Optical Coherence Tomography | Cutaneous Tumor

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies (SURPASSe)

Sezary Syndrome | Cutaneous T Lymphoma

France
Assistance Publique - Hôpitaux de Paris
Société de Dermatologie Française

Completed

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy (SPIREPI)

Cutaneous Atrophy Due to Corticosteroids

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor Prognosis (CUTALLO)

Epidermotropic T-cell Lymphomas

France
Centre Hospitalier Universitaire de Besancon

Recruiting

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy (MORPHEE)

Cutaneous T-Cell Lymphoma | Graft Rejection | Graft Vs Host Disease

France
European Organisation for Research and Treatment...

Terminated

REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (REACH)

Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)

France
Kyowa Kirin, Inc.

Active, not recruiting

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Cutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, Relapsed

United States, United Kingdom, Spain, France, Italy
University Hospital, Toulouse

Completed

Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language (Mc_QoL)

Indolent Systemic Mastocytosis | Cutaneous Mastocytosis

France
European Organisation for Research and Treatment...

Recruiting

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma (MOGAT)

Stage IB-IIB Cutaneous T-Cell Lymphoma

Spain, United Kingdom, Denmark, Italy, France, Germany, Greece
Innovent Biologics (Suzhou) Co. Ltd.
Innovent Biologics (USA), Inc.

Withdrawn

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma

United States, Germany, France, Australia, Spain, Switzerland, United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Metastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...

United States, Canada, Ireland
Foundation for Liver Research
Cook Ireland, Ltd.

Completed

Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS (ASPRO)

Pancreatic Masses | Lymph Nodes

France, Sweden, Israel, Belgium, Australia, United States, Italy, Japan, Netherlands, Spain
Celgene
Celgene Corporation

Completed

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Cutaneous T-cell Lymphoma

United States, France, Germany, Poland, Russian Federation, United Kingdom
Pfizer

Completed

Use of 852A in Metastatic Cutaneous Melanoma.

Melanoma | Unresectable Metatstatic Cutaneous Melanoma

Switzerland, Germany, France
University Hospital, Bordeaux

Completed

Cell-free Circulating DNA in Primary Cutaneous Lymphomas (MATULILA)

Mycosis Fungoides | Lymphoma, Large B-cell, Diffuse

France
University Hospital, Bordeaux

Completed

Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma (REV-LEG)

Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)

France
miRagen Therapeutics, Inc.

Terminated

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

United States, France, Belgium
Bristol-Myers Squibb

Withdrawn

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

Lymphoma, Large-Cell

United States, France
Centre Antoine Lacassagne

Completed

Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study (C3)

Squamous Cell Cutaneous Carcinoma of the Skin

France
Biogen

Recruiting

A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

Subacute Cutaneous Lupus Erythematosus | Chronic Cutaneous Lupus Erythematosus

United States, Italy, Korea, Republic of, Taiwan, Argentina, Chile, Spain, Canada, Serbia, France, Germany, Japan, Brazil, United Kingdom, Bulgaria, Portugal, Switzerland, Philippines, Saudi Arabia, Sweden, Mexico, Poland, Hungary, Puerto... and more
Zimmer, GmbH

Active, not recruiting

Zimmer POLAR Persona - TKA (EMEA Study)

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis | Polyarthritis | Severe Knee Pain | Severe Knee Disability

France, Spain, United Kingdom, Austria, Germany, Netherlands
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Lupus Erythematosus, Discoid | Lupus Erythematosus, Subacute Cutaneous

Mexico, Argentina, Australia, United States, France, Germany, Poland, Taiwan
Innate Pharma

Completed

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

Cutaneous T-Cell Lymphoma

United States, France, Netherlands, United Kingdom
National Cancer Institute (NCI)

Suspended

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy in Patients With Operable Melanoma

Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma

United States
Takeda

Recruiting

A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin

T-Cell Lymphoma

France, Germany, Spain, Italy
Replimune Inc.
Regeneron Pharmaceuticals

Active, not recruiting

Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer (CERPASS)

Cutaneous Squamous Cell Carcinoma | Advanced Cutaneous Squamous Cell Carcinoma | Metastatic Cutaneous Squamous Cell Carcinoma

Spain, United States, France, Australia, Germany, Canada, Greece, Bulgaria, Italy, Poland
Assistance Publique - Hôpitaux de Paris

Completed

Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma (KIR)

Dermatitis | Sezary Syndrome | Dermatitis, Exfoliative | Mycosis Fungicides

France
National Cancer Institute (NCI)

Active, not recruiting

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7

United States

Clinical Trials on Cutaneous Polyarteritis Nodosa in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations